Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function

American Journal of Pathology

Volumn 181, Issue 1, 2012, Pages 196-210

  Rynda Apple, Agnieszka ^a   Dobrinen, Erin ^a   McAlpine, Mark ^a   Read, Amanda ^a   Harmsen, Ann ^a   Richert, Laura E ^a   Calverley, Matthew ^a   Pallister, Kyler ^a   Voyich, Jovanka ^a   Wiley, James A ^a   Johnson, Ben ^a   Young, Mark ^a   Douglas, Trevor ^a   Harmsen, Allen G ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; COAT PROTEIN P22 VIRUS LIKE AGENT; INTERLEUKIN 13; NANOPARTICLE; PROTEIN CAGE NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CD11C+ CELL; CELL FUNCTION; CHEMOTAXIS; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG INJURY; LY6G+ CELL; MACROPHAGE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REACTION TIME; SEVERE COMBINED IMMUNODEFICIENCY; TISSUE NECROSIS; VIRUS LIKE AGENT; WILD TYPE;

ADAPTIVE IMMUNITY; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, CD11C; BACTERIAL LOAD; DENDRITIC CELLS; FEMALE; IMMUNOPHENOTYPING; INTERLEUKIN-13; LUNG; MACROPHAGES, ALVEOLAR; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MONOCYTES; NEUTROPHILS; PHAGOCYTES; PHAGOCYTOSIS; PNEUMONIA, STAPHYLOCOCCAL; STAPHYLOCOCCAL VACCINES; TIME FACTORS; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84862646143     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.03.018     Document Type: Article

References (67)

1. Walzl G, Tafuro S, Moss P, Openshaw PJ, Hussell T: Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J Exp Med 2000, 192:1317-1326
2. Folkerts G, Walzl G, Openshaw PJ: Do common childhood infections "teach" the immune system not to be allergic? Immunol Today 2000, 21:118-120
3. Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, Selin LK: Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2001, 2:1067-1076
4. Chen HD, Fraire AE, Joris I, Welsh RM, Selin LK: Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 2003, 163:1341-1355
5. Walzl G, Humphreys IR, Marshall BG, Edwards L, Openshaw PJ, Shaw RJ, Hussell T: Prior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent manner. Infect Immun 2003, 71:3384-3391
6. Williams AE, Edwards L, Hussell T: Colonic bacterial infection abrogates eosinophilic pulmonary disease. J Infect Dis 2006, 193:223-230
7. Wissinger E, Goulding J, Hussell T: Immune homeostasis in the respiratory tract and its impact on heterologous infection. Semin Immunol 2009, 21:147-155
8. Edwards L, Williams AE, Krieg AM, Rae AJ, Snelgrove RJ, Hussell T: Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner. Eur J Immunol 2005, 35:273-281
9. Williams AE, Edwards L, Humphreys IR, Snelgrove R, Rae A, Rappuoli R, Hussell T: Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J Immunol 2004, 173:7435-7443
10. Watkins AC, Caputo FJ, Badami C, Barlos D, Xu da Z, Lu Q, Feketeova E, Deitch EA: Mesenteric lymph duct ligation attenuates lung injury and neutrophil activation after intraperitoneal injection of endotoxin in rats. J Trauma 2008, 64:126-130
11. Wang J, Barke RA, Charboneau R, Schwendener R, Roy S: Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling. J Immunol 2008, 180:3594-3600
12. Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B: Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005, 6:68
13. Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE: Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol 2007, 179:6097-6106
14. Wiley JA, Richert LE, Swain SD, Harmsen A, Barnard DL, Randall TD, Jutila M, Douglas T, Broomell C, Young M, Harmsen AG: Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. PLoS One 2009, 4:e7142
15. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD: Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006, 116:3183-3194
16. Flenniken ML, Willits DA, Harmsen AL, Liepold LO, Harmsen AG, Young MJ, Douglas T: Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture. Chem Biol 2006, 13:161-170
17. Kaiser CR, Flenniken ML, Gillitzer E, Harmsen AL, Harmsen AG, Jutila MA, Douglas T, Young MJ: Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int J Nanomedicine 2007, 2:715-733
18. Jennings GT, Bachmann MF: The coming of age of virus-like particle vaccines. Biol Chem 2008, 389:521-536
19. Lechmann M, Murata K, Satoi J, Vergalla J, Baumert TF, Liang TJ: Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice. Hepatology 2001, 34:417-423
20. Zhang S, Liang M, Gu W, Li C, Miao F, Wang X, Jin C, Zhang L, Zhang F, Zhang Q, Jiang L, Li M, Li D: Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice. Virol J 2011, 8:333
21. Velasquez LS, Shira S, Berta AN, Kilbourne J, Medi BM, Tizard I, Ni Y, Arntzen CJ, Herbst-Kralovetz MM: Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine 2011, 29:5221-5231
22. Herbst-Kralovetz M, Mason HS, Chen Q: Norwalk virus-like particles as vaccines. Expert Rev Vaccines 2010, 9:299-307
23. Barr E, Sings HL: Prophylactic HPV vaccines: new interventions for cancer control. Vaccine 2008, 26:6244-6257
24. Harper DM: Currently approved prophylactic HPV vaccines. Expert Rev Vaccines 2009, 8:1663-1679
25. Chackerian B, Rangel M, Hunter Z, Peabody DS: Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses. Vaccine 2006, 24:6321-6331
26. Fulurija A, Lutz TA, Sladko K, Osto M, Wielinga PY, Bachmann MF, Saudan P: Vaccination against GIP for the treatment of obesity. PLoS One 2008, 3:e3163
27. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK: Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771
28. Boucher HW, Corey GR: Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008, 46(Suppl 5):S344-S349
29. Miller LS, Cho JS: Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 2011, 11:505-518
30. Graves SF, Kobayashi SD, DeLeo FR: Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence. J Mol Med (Berl) 2010, 88:109-114
31. Deleo FR, Otto M, Kreiswirth BN, Chambers HF: Community-associated methicillin-resistant Staphylococcus aureus. Lancet 2010, 375:1557-1568
32. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hansel NN, Perl T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Bartlett JG: Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005, 40:100-107
33. Boles BR, Thoendel M, Roth AJ, Horswill AR: Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 2010, 5:e10146
34. Siemen DW, Schepetkin IA, Kirpotina LN, Lei B, Quinn MT: Neutrophil Isolation from Nonhuman Species. Methods in Molecular Biology 2007, 412:21-34
35. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella SF, Long RD, Dorward DW, Gardner DJ, Kreiswirth BN, Musser JM, DeLeo FR: Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005, 175:3907-3919
36. Prevelige PEJ: The Bacteriophages. Edited by Calendar, R. New York, Oxford University Press, 2005, pp 457-468
37. Steinmetz NF, Manchester M. Overview of the manifold VNPs used in nantechnology. Viral Nonoparticles: Tools for Material Science and Biomedicine, vol 1, ed 1, ch 2. Edited by M Manchester. Singapore, Pan Stanford Publishing Pte. Ltd., 2011, pp 13-48
38. Sonozaki H, Cohen S: The macrophage disappearance reaction: mediation by a soluble lymphocyte-derived factor. Cell Immunol 1971, 2:341-352
39. Gu J, Zuo J, Lei L, Zhao H, Sun C, Feng X, Du C, Li X, Yang Y, Han W: LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice. Bioeng Bugs 2011, 2:96-99
40. Watkins RL, Pallister KB, Voyich JM: The SaeR/S gene regulatory system induces a pro-inflammatory cytokine response during Staphylococcus aureus infection. PLoS One 2011, 6:e19939
41. Goulding J, Snelgrove R, Saldana J, Didierlaurent A, Cavanagh M, Gwyer E, Wales J, Wissinger EL, Hussell T: Respiratory infections: do we ever recover? Proc Am Thorac Soc 2007, 4:618-625
42. Kugathasan K, Roediger EK, Small CL, McCormick S, Yang P, Xing Z: CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naive and antigen-primed T cells. BMC Immunol 2008, 9:48
43. Fei M, Bhatia S, Oriss TB, Yarlagadda M, Khare A, Akira S, Saijo S, Iwakura Y, Fallert Junecko BA, Reinhart TA, Foreman O, Ray P, Kolls J, Ray A: TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc Natl Acad Sci U S A 2011, 108:5360-5365
44. Sung SS, Fu SM, Rose CE Jr, Gaskin F, Ju ST, Beaty SR: A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 2006, 176:2161-2172
45. Kim TS, Braciale TJ: Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One 2009, 4:e4204
46. Martin FJ, Parker D, Harfenist BS, Soong G, Prince A: Participation of CD11c+ leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung. Infect Immun 2011, 79:1898-1904
47. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969
48. Wojcik AJ, Skaflen MD, Srinivasan S, Hedrick CC: A critical role for ABCG1 in macrophage inflammation and lung homeostasis. J Immunol 2008, 180:4273-4282
49. Robertson CM, Perrone EE, McConnell KW, Dunne WM, Boody B, Brahmbhatt T, Diacovo MJ, Van Rooijen N, Hogue LA, Cannon CL, Buchman TG, Hotchkiss RS, Coopersmith CM: Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance. J Surg Res 2008, 150:278-285
50. Senavsky C, Craft N, Miller LS: Bacterial Infections. Edited by AA Gaspary, SK Tyring. Springer, London, UK, 2008, pp 335-363
51. Heyworth PG, Cross AR, Curnutte JT: Chronic granulomatous disease. Curr Opin Immunol 2003, 15:578-584
52. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF: Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997, 100:2552-2561
53. Lenz P, Day PM, Pang YY, Frye SA, Jensen PN, Lowy DR, Schiller JT: Papillomavirus-like particles induce acute activation of dendritic cells. J Immunol 2001, 166:5346-5355
54. Lacasse P, Denis J, Lapointe R, Leclerc D, Lamarre A: Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation. J Virol 2008, 82:785-794
55. Jennings JH, Linderman DJ, Hu B, Sonstein J, Curtis JL: Monocytes recruited to the lungs of mice during immune inflammation ingest apoptotic cells poorly. Am J Respir Cell Mol Biol 2005, 32:108-117
56. Behar SM, Martin CJ, Booty MG, Nishimura T, Zhao X, Gan HX, Divangahi M, Remold HG: Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol 2011, 4:279-287
57. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, Kennedy AD, Sampaio E, Kristosturyan E, Whitney AR, Sturdevant DE, Dorward DW, Holland SM, Kreiswirth BN, Musser JM, DeLeo FR: Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2010, 2:560-575
58. Skold M, Behar SM: Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J Immunol 2008, 181:6349-6360
59. Cheung GY, Rigby K, Wang R, Queck SY, Braughton KR, Whitney AR, Teintze M, DeLeo FR, Otto M: Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathog 2010, 6:e1001133
60. Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L, Mai TT, Marbach H, Braughton KR, Whitney AR, Gardner DJ, Fan X, Tseng CW, Liu GY, Badiou C, Etienne J, Lina G, Matthay MA, DeLeo FR, Chambers HF: Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A 2010, 107:5587-5592
61. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP: Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 2000, 164:3713-3722
62. Ghassabeh GH, De Baetselier P, Brys L, Noel W, Van Ginderachter JA, Meerschaut S, Beschin A, Brombacher F, Raes G: Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 2006, 108:575-583
63. Martinez FO, Sica A, Mantovani A, Locati M: Macrophage activation and polarization. Front Biosci 2008, 13:453-461
64. Nelson MP, Christmann BS, Werner JL, Metz AE, Trevor JL, Lowell CA, Steele C: IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J Immunol 2011, 186:2372-2381
65. Girard D, Paquin R, Naccache PH, Beaulieu AD: Effects of interleukin-13 on human neutrophil functions. J Leukoc Biol 1996, 59:412-419
66. Shim JJ, Dabbagh K, Ueki IF, Dao-Pick T, Burgel PR, Takeyama K, Tam DC, Nadel JA: IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 2001, 280:L134-L140
67. Olszewski MA, Falkowski NR, Surana R, Sonstein J, Hartman A, Moore BB, Huffnagle GB, Toews GB: Effect of laparotomy on clearance and cytokine induction in Staphylococcus aureus infected lungs. Am J Respir Crit Care Med 2007, 176:921-929